These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19393215)

  • 1. Correcting autoimmune anomalies in autoimmune disorders by immunological means, employing the modified vaccination technique.
    Barabas AZ; Cole CD; Barabas AD; Graeff RM; Lafreniere R; Weir DM
    Autoimmun Rev; 2009 Jun; 8(7):552-7. PubMed ID: 19393215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified vaccination technique for prophylactic and therapeutic applications to combat endogenous antigen-induced disorders.
    Barabas AZ; Cole CD; Barabas AD; Graeff RM; Lafreniere R; Weir DM
    Scand J Immunol; 2010 Mar; 71(3):125-33. PubMed ID: 20415778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A modified vaccination technique for the prevention and treatment of an experimental autoimmune kidney disease.
    Barabas AZ; Cole CD; Barabas AD; Lafreniere R
    Ann N Y Acad Sci; 2007 Sep; 1110():619-29. PubMed ID: 17911477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated antibody response by antigen presentation in immune complexes.
    Barabas AZ; Cole CD; Kovacs ZB; Lafreniere R
    Med Sci Monit; 2007 May; 13(5):BR119-24. PubMed ID: 17476190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New vaccination technology for endogenous antigen-derived ailments.
    Barabas AZ; Cole CD; Barabas AD; Bahlis NJ; Lafreniere R
    IDrugs; 2008 Feb; 11(2):111-5. PubMed ID: 18240096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance, loss of tolerance and regaining tolerance to self by immune-mediated events.
    Barabas AZ; Cole CD; Graeff RM; Lafreniere R; Weir DM
    Immunol Res; 2017 Feb; 65(1):402-409. PubMed ID: 27456203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of autoimmunologists in investigating and treating autoimmune disorders.
    Barabas AZ; Cole CD; Graeff RM; Lafreniere R; Weir DM
    Autoimmun Rev; 2011 Jan; 10(3):166-70. PubMed ID: 20887816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel modified vaccination technique produces IgG antibodies that cause complement-mediated lysis of multiple myeloma cells carrying CD38 antigen.
    Barabas AZ; Cole CD; Graeff RM; Morcol T; Lafreniere R
    Hum Antibodies; 2016; 24(3-4):45-51. PubMed ID: 28128764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The modified vaccination technique designed to prevent and cure acute and chronic disorders.
    Barabas AZ; Cole CD; Kovacs ZB; Kovacs EI; Lafreniere R; Weir DM
    Hum Antibodies; 2020; 28(2):111-121. PubMed ID: 31594214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypotheses on a germline origin of antibody diversity. Possible applications: improvement of the efficiency of immune response and autoimmune disease treatment.
    Berger G
    Med Hypotheses; 2004; 63(5):847-54. PubMed ID: 15488659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventative and therapeutic vaccination to combat an experimental autoimmune kidney disease.
    Barabas AZ; Cole CD; Barabas AD; Lafreniere R
    Biologics; 2007 Mar; 1(1):59-68. PubMed ID: 19707349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-initiated beneficial and harmful immune responses.
    Barabas AZ; Cole CD; Lafreniere R
    Immunol Res; 2018 Dec; 66(6):783-789. PubMed ID: 30456543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How the immune system achieves self-nonself discrimination during adaptive immunity.
    Jiang H; Chess L
    Adv Immunol; 2009; 102():95-133. PubMed ID: 19477320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy and bone marrow stem-cell transfer to treat autoimmune disease.
    Alderuccio F; Chan J; Scott DW; Toh BH
    Trends Mol Med; 2009 Aug; 15(8):344-51. PubMed ID: 19665432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with cytokines in autoimmune diseases.
    Delavallée L; Assier E; Denys A; Falgarone G; Zagury JF; Muller S; Bessis N; Boissier MC
    Ann Med; 2008; 40(5):343-51. PubMed ID: 18484346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Number of vaccinations performed and immunological system].
    Bucholc B; Górska P; Janaszek-Seydlitz W
    Przegl Epidemiol; 2011; 65(4):629-34. PubMed ID: 22390051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination in adults with auto-immune disease and/or drug related immune deficiency: results of the GEVACCIM Delphi survey.
    Duchet-Niedziolka P; Launay O; Coutsinos Z; Ajana F; Arlet P; Barrou B; Beytout J; Bouchaud O; Brouqui P; Buzyn A; Chidiac C; Couderc LJ; Debord T; Dellamonica P; Dhote R; Duboust A; Durrbach A; Fain O; Fior R; Godeau B; Goujard C; Hachulla E; Marchou B; Mariette X; May T; Meyer O; Milpied N; Morlat P; Pouchot J; Tattevin P; Viard JP; Lortholary O; Hanslik T;
    Vaccine; 2009 Mar; 27(10):1523-9. PubMed ID: 19168104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Knowledge of the MCHII-processing is crucial for the development of new vaccination strategies].
    van Houten D
    Tijdschr Diergeneeskd; 2012 Jul; 137(7):462-3. PubMed ID: 22900423
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccination of the immune-compromised patients with focus on patients with autoimmune-inflammatory diseases.
    Bijl M; Kallenberg CG; van Assen S
    Neth J Med; 2011 Jan; 69(1):5-13. PubMed ID: 21325695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regaining tolerance to a self-antigen by the modified vaccination technique.
    Barabas AZ; Cole CD; Lafreniere R; Weir DM
    Clin Rev Allergy Immunol; 2013 Oct; 45(2):193-201. PubMed ID: 23296949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.